- Home
- PRME vs HKD Comparison
PRME vs HKD Comparison
Compare PRME & HKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- HKD
- Stock Information
- Founded
- PRME 2019
- HKD 2003
- Country
- PRME United States
- HKD France
- Employees
- PRME N/A
- HKD N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- HKD Finance: Consumer Services
- Sector
- PRME Health Care
- HKD Finance
- Exchange
- PRME Nasdaq
- HKD Nasdaq
- Market Cap
- PRME 601.1M
- HKD 656.8M
- IPO Year
- PRME 2022
- HKD 2022
- Fundamental
- Price
- PRME $3.41
- HKD $1.57
- Analyst Decision
- PRME Buy
- HKD
- Analyst Count
- PRME 6
- HKD 0
- Target Price
- PRME $9.31
- HKD N/A
- AVG Volume (30 Days)
- PRME 3.8M
- HKD 17.5M
- Earning Date
- PRME 11-07-2025
- HKD 01-01-0001
- Dividend Yield
- PRME N/A
- HKD N/A
- EPS Growth
- PRME N/A
- HKD N/A
- EPS
- PRME N/A
- HKD N/A
- Revenue
- PRME $5,977,000.00
- HKD $87,436,000.00
- Revenue This Year
- PRME $179.58
- HKD N/A
- Revenue Next Year
- PRME N/A
- HKD N/A
- P/E Ratio
- PRME N/A
- HKD $13.79
- Revenue Growth
- PRME 647.13
- HKD N/A
- 52 Week Low
- PRME $1.11
- HKD $1.52
- 52 Week High
- PRME $6.94
- HKD $5.47
- Technical
- Relative Strength Index (RSI)
- PRME 35.80
- HKD 43.28
- Support Level
- PRME $3.45
- HKD $1.63
- Resistance Level
- PRME $4.00
- HKD $1.77
- Average True Range (ATR)
- PRME 0.41
- HKD 0.42
- MACD
- PRME -0.15
- HKD -0.05
- Stochastic Oscillator
- PRME 11.14
- HKD 0.35
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About HKD AMTD Digital Inc. (every five of which represent two)
AMTD Digital Inc along with its subsidiaries, is mainly involved in the provision of digital solutions services. Its reportable segments are digital solutions services segment, hotel operations, hospitality and VIP services segment and media and entertainment services. The company generates maximum revenue by providing financial digital solutions through its insurance brokerage services and other digital solutions services. Geographically, the company generates maximum revenue from Hong Kong and Singapore.